Walvax Biotechnology Faces Investor Scrutiny Amid Financial Concerns and Market Valuation Challenges
Walvax Biotechnology Co Ltd’s recent financial disclosures raise concerns about its valuation and market strategy, with a high P/E ratio, low stock price, and uncertain market positioning.
3 minutes to read